Bezuclastinib mean TSS reduction deepens to –32.0 points at 48 weeks of treatment with further improvement shown across all measured symptoms99% ...

56% mean improvement in Total Symptom Score (TSS) at 24 weeks with 76% of patients achieving at least a 50% reduction in TSS 89% of patients had >50% decrease in serum tryptase by four weeks of ...

Reference ranges for basal serum tryptase (BST) are an excellent guide to determining whether a patient’s BST value is normal, per their specific tryptase genotype. If the BST is elevated based on the ...

Please provide your email address to receive an email when new articles are posted on . Patients with alpha tryptase had more anaphylaxis than patients who only had B-tryptase. 65% of patients with ...

In a decade-long study, a ratio of serum acute tryptase to serum baseline tryptase above 1.74 showed superior diagnostic performance compared with the current consensus formula, which requires serum ...